12th Global Pharma Conference & Expo
Download Brochure

Track 19: Drug Regulations


Drugs are substances that have been explicitly approved for use in treating, diagnosing, curing, or preventing a disease or ailment by an official Pharmacopeia and Formulary. A medical substance causes a change in the patient's body's structure or function.

For the public's health and safety, drug and medical control is essential. By examining the drug's efficacy, quality, and safety, it is possible to ensure that a medicine is of high quality. The medications are made, manufactured, kept, and distributed in accordance with the health and safety standards established by qualified and experienced chemists and pharmacists. The manufacture of medications in a dishonest or unlawful manner is forbidden by the FDA (Food and Drug Administration) and other health regulatory agencies.

11th Global Pharma Conference and Expo

Every stage and process that the medication material goes through requires strict adherence to regulation. These procedures—which are necessary for the proper upkeep of medications as well as for the safety and health of consumers—include raw material handling, formula applications, lot number maintenance, humidity, light, and temperature control, storage, special packs for sensitive medications, SOPs for medication movement, refrigerator use, legal documents and records, shipping, and handling.

The authorities should be in charge of drug regulations. The national government, which is represented by medical regulatory authority, may be in charge of activating the national medical regulatory board (MRAs). The regulatory agencies are in charge of making sure that all pharmaceutical manufacture complies with the laws, rules, and morality standards specified by national and international organisations.

The governing board makes sure that every member of staff is qualified, including labour, technicians, pharmacists, and chemists. Regular checks are done to make sure quality control is followed in the equipment, distributors, technical literature, and manufacturing divisions, among other places. The regulatory body, the government, and the people are all held responsible for all matters of compliance. To maintain the success of the nation, decisions made by the authorities must be transparent, explicit, and made in accordance with the law.

The FDA monitors compliance with the CGMP (Current Good Manufacturing Practices) rules by pharmaceutical businesses and organisations. If the circumstances and standard operating procedures are not followed when manufacturing pharmaceuticals, there is a chance that the drugs could become contaminated, which would degrade their quality and put patients at risk for illnesses that could be damaging, hazardous, or even fatal. When not maintained or managed appropriately, drugs, especially those that are sensitive, can easily change their structure and components at any point.

Due to these factors, stringent regulatory plans, legal requirements, and implementation procedures must be followed. As a result, there are far fewer accidents in the medical field.


Our Speakers For 11th Global 
Pharma Conference and Expo